GENMAB AS
HQ - Copenhagen
Summary
Genmab is a biotechnology company that focuses on the development and commercialization of differentiated antibody therapeutics for the treatment of cancer.
Deals Overview
Total Deals2
Valued Deals2
Total Value£ 7.33 B
Avg. Deal Size£ 3.67 B
All rights reserved. Copyright © 2025 Datasite
